• Return to Headlines

Shares of Bristol-Myer Sqb Rise to a New 52-Week High

By James Quinn

Shares of Bristol-Myer Sqb (NYSE:BMY) traded today at $56.74, breaking its 52-week high. So far today approximately 3.2 million shares have been exchanged, as compared to an average 30-day volume of 8.6 million shares.

Bristol-Myer Sqb (NYSE:BMY) has potential upside of 3.4% based on a current price of $56.62 and analysts' consensus price target of $58.56. Bristol-Myer Sqb shares have support at the 50-day moving average (MA) of $49.32 and additional support at the 200-day MA of $48.02.

Bristol-Myer Sqb share prices have moved between a 52-week high of $56.74 and a 52-week low of $42.48 and are now trading 33% above that low price at $56.62 per share. Over the last five market days, the 200-day moving average (MA) has remained constant while the 50-day MA has advanced 0.7%.

Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol-Myers Squibb products and experimental therapies address cancer, heart disease, HIV and AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.

SmarTrend is tracking the current trend status for Bristol-Myer Sqb and will alert subscribers who have BMY in their portfolio or watchlist when shares have changed trend direction.

Keywords: 52 week high/lows bristol-myer sqb

Ticker(s): BMY